35th Annual Columbia And Cornell Update in Gastroenterology And Hepatology 2018

Topics

• Improving the ability to monitor and both optimize and personalize the dosing of anti-TNF agents
• New pharmacotherapy in the treatment of Inflammatory Bowel Disease, including treating Crohn’s disease and ulcerative colitis, and enhanced surgical treatments for IBD
• The safety profile of various therapeutics in treating IBD in the pregnant patient
• The role and appropriate use of use anti-integrin therapy
• New developments in the treatment of C. difficile colitis
• The role of new therapies for hepatitis B, hepatitis C, and hepatocellular carcinoma
• The endoscopic management of esophageal cancer
• The utility of pharmacologic and endoscopic therapies for reflux disease and Barrett’s esophagus
• Determining appropriate candidates for ablation of Barrett’s esophagus
• The role of endoscopic mucosal dissection and endoscopic surgery and STER for treating early GI malignancies
• The role of therapeutic endoscopic ultrasound in clinical practice
• The role of new endoscopic techniques such as POEM for treating achalasia
• Novel endoscopic techniques for improving care of patients with complicated hepatobiliary diseases and pancreatitis
• The potential role for probiotics in the management of gastrointestinal disorders
• Current treatment options for chronic pancreatitis
• The clinical utility of endoscopic techniques for managing pancreatic fluid collections
• Optimal dosing strategies for colonoscopy bowel preparation so as to improve adenoma detection and colon cancer prevention
• How to evaluate and treat patients with upper gastrointestinal motility and functional bowel disorders